This is a ready-to-use program plan for a data integrity (DI) remediation. It is the governing document above the individual CAPAs and protocols: it sets the workstreams, the governance cadence, the retrospective review, commitment tracking, and the path to sustainable compliance. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your program governance. A worked filled specimen follows. Verify each cited regulation against the current source before you rely on it.
Document control header
| Field | Entry |
|---|---|
| Document title | Data Integrity Remediation Program Plan, <<FILL: SITE>> |
| Document number | <<FILL: PLAN-ID, e.g. REM-PLAN-001>> |
| Version | <<FILL: version>> |
| Effective date | <<FILL: date>> |
| Executive sponsor | <<FILL: name, role>> |
| Program manager | <<FILL: name, role>> |
| Regulatory trigger | <<FILL: warning letter / 483 / non-compliance statement, date and reference>> |
1. Scope and objective
Remediate the DI findings in <<FILL: reference>> and the systemic failures that allowed them, at <<FILL: SITE>>, to a state the agency will judge adequate at a follow-up inspection, and then embed the preventive controls into the routine quality system so the failures cannot return. Scope covers the observed findings and the systems, procedures, training, culture, and data implicated by them, not only the specific items named.
2. Approach and risk basis
The program addresses each observation as a symptom of a system. Every observation maps to its cited regulation and the systems it touches (see the Day 1 triage worksheet), and remediation is sequenced so the systems tied to released product are fixed first. The retrospective review determines the true scope; new findings loop back into containment and CAPA and are disclosed in writing. Timelines are set honestly; the program is planned to run <<FILL: e.g. 18-36>> months and to be non-linear.
3. Workstreams
| # | Workstream | Focus | Typical duration | Primary owner |
|---|---|---|---|---|
| 1 | Immediate containment | Stop active risk; manual compensating controls | 0-2 months | QA + operations |
| 2 | Technical remediation | Audit trails, access, backup, time sync, validation | 6-24 months | IT / CSV / engineering |
| 3 | Procedural remediation | DI policy and supporting SOPs, not generic | 2-9 months | Quality systems |
| 4 | Training | Role-based DI training with effectiveness checks | 2-12 months, then ongoing | Training + QA |
| 5 | Culture and leadership | The conditions that allowed the failures | Continuous | Site leadership |
| 6 | Retrospective data review | Determine true scope and product impact | 3-18 months | QC + QA + forensics |
Compensating controls in workstream 1 are explicitly temporary; the plan states when each is replaced by a validated control, and they are not lifted early.
4. Governance and cadence
| Body | Frequency | Chair | Purpose |
|---|---|---|---|
| Workstream lead meeting | Weekly | Program manager | Status, blockers, new findings |
| Steering committee | Monthly | Executive sponsor | Decisions, resources, agency posture |
| New-findings review | Standing agenda item | QA | Assess, disclose, route to CAPA |
Every workstream reports in the same format: percent complete, milestones met versus planned, open risks, and any new findings.
5. Commitment and disclosure management
- Maintain a single commitment register listing every promise made in every response, its due date, owner, and status; review it at every steering committee.
- Any finding discovered during the retrospective review is disclosed to the agency in writing. Withholding a finding is treated as a breach of the response commitment.
- If a committed date cannot be met, communicate in advance with the reason and a revised date.
6. Retrospective data review
The review scope, boundary rationale, systems, reconciliation methodology, classification of findings, product impact, and disclosure are defined in the retrospective review protocol. The program plan requires that the review boundary be risk-justified and documented, and that an independent reviewer confirm the methodology.
7. Third-party verification
For a significant remediation, an independent third party reviews the program and attests to its completeness and durability. The plan defines the third party’s scope in writing, gives it real access, and lets it report without editing. Its independence is stated in the engagement letter.
8. Deliverables
| Deliverable | Reference | Owner |
|---|---|---|
| Day 1 observation triage worksheet | <<FILL>> | Program manager |
| Integrated project plan | <<FILL>> | Program manager |
| Initial and detailed responses | <<FILL>> | Regulatory affairs |
| DI policy and supporting SOPs | <<FILL>> | Quality systems |
| System remediation and revalidation records | <<FILL>> | IT / CSV |
| Retrospective review protocol and report | <<FILL>> | QC + QA |
| Commitment register | <<FILL>> | Program manager |
| Third-party verification report | <<FILL>> | Executive sponsor |
| Sustainability handoff to the routine QMS | <<FILL>> | Head of Quality |
9. Schedule and milestones
| Milestone | Target date | Dependency |
|---|---|---|
| Executive sponsor and PMO named | <<FILL>> | - |
| Written response submitted | <<FILL: within 15 business days>> | Containment underway |
| Retrospective review scope approved | <<FILL>> | Triage complete |
| Technical remediation of release-critical systems | <<FILL>> | - |
| Retrospective review complete and disclosed | <<FILL>> | - |
| Follow-up inspection readiness | <<FILL>> | All workstreams |
| Sustainability handoff | <<FILL>> | Closeout |
10. Acceptance criteria for the program
- Every observation is mapped to its regulation and system and addressed at correction, corrective, and preventive levels.
- The retrospective review is complete, its boundary risk-justified, and all findings disclosed.
- Systems are remediated and revalidated, procedures are specific to the real gaps, and training has effectiveness evidence.
- All commitments in every response were met on their dates, or renegotiated in advance.
- The preventive controls are embedded in the routine quality system with named owners.
11. References
FDA, Data Integrity and Compliance With Drug CGMP: Questions and Answers (2018). MHRA, GXP Data Integrity Guidance and Definitions (2018). WHO Guideline on Data Integrity (Technical Report Series, 2021) (reference by title; describe, do not paste). PIC/S PI 041, Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments (2021) (reference by title; describe, do not paste). ICH Q10, Pharmaceutical Quality System, for management review and the sustainable state. 21 CFR Part 211 and 21 CFR Part 11 for the underlying US requirements.
Confirm the current version and clause numbers of each reference before issue.
12. Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL: date>> | <<FILL>> | Initial program plan. |
13. Approvals
| Role | Name | Signature | Date |
|---|---|---|---|
| Executive sponsor | <<FILL>> | ||
| Program manager | <<FILL>> | ||
| Head of Quality | <<FILL>> |
Filled specimen
The following shows the plan header and governance completed for an illustrative site. Details are illustrative.
- Trigger: Warning Letter WL-000-2026 citing disabled CDS audit trails, shared LIMS logins, and unexplained “trial” injections.
- Executive sponsor: VP Site Quality; program manager: full-time, supported by a two-person PMO.
- Planned duration: 24 months, non-linear, with the retrospective review expected to surface additional findings.
- Cadence: weekly workstream leads, monthly steering committee chaired by the sponsor, new findings a standing agenda item.
- First milestones: written response at day 14; retrospective scope approved at week 6; release-critical CDS remediated by month 6.
This plan reads as a program under control: a senior sponsor who can release resources, a full-time PMO, a realistic non-linear timeline, and a governance structure that expects and discloses new findings rather than hiding them.
Common inspection findings this plan prevents
- Remediation run as a single CAPA with no program structure, so scope and ownership blur.
- An executive sponsor too junior to release budget, so the program stalls.
- A retrospective review left to whoever has spare time, so the true scope is never determined.
- Compensating controls lifted before the validated control is in place.
- The program disbanding with no handoff, so controls quietly drift once the team disperses.
How to adapt this plan
- Name a senior executive sponsor and a full-time program manager before anything else.
- Map the workstreams to your actual findings and sequence release-critical systems first.
- Set an honest, non-linear timeline and a governance cadence that surfaces new findings.
- Stand up the commitment register and the disclosure discipline from day one.
- Define the sustainability handoff so the preventive controls live in the routine QMS after closeout.